ESCMID offers research grants for its members ranging from early career support to large-scale translational projects. The current call for individual research grants will support projects focused on fungal/viral/parasitic infections and diseases – and it is closing soon on 12 September. This grant aims to support early career scientists get their possibly first grant funding and propel them into their research journey.

Science & Research

The Emerging Infections Subcommittee has published an update on mpox (2 September 2024). This compilation includes the latest news, publications, and resources, covering recent developments such as vaccine distribution in Africa and WHO policy updates. It provides links to '2022-2024 Mpox Outbreak: Global Trends,' which features interactive dashboards and epidemiological data. This update offers a brief overview of the developments of the mpox situation for healthcare professionals, researchers, and policymakers.

Don’t forget to register for this upcoming REVIVE webinar on 19 September! It will give an introduction to the stages of this process, from discovery to the phases of clinical trials and pharmaceutical development. A must-watch for students, clinicians or anyone interested in learning more about what is being done to control AMR.

Education

Embark on a comprehensive journey into the realm of Vector-Borne Diseases (VBD) with our dynamic course designed to equip participants with essential knowledge and skills. Delve into the intricacies of the most prevalent VBD, honing your understanding of the vectors responsible for their transmission and mastering effective prevention strategies.

Registration is open until 22 September 2024.

The call for 50 Funded Observerships will open next week on 10 September. ESCMID Observerships provide participants with a fantastic opportunity to gain experience and exchange knowledge with colleagues across the fields of CM & ID. Choose and contact your target institution among 123 ESCMID Collaborative Centres, to get started.

Congress & Events

There are still seats available, so be sure to register now to take part in this event that covers academia, industry and political themes surrounding drug development and AMR. The 2024 ESCMID/ASM joint conference: Meet the Challenge of AMR takes place in Porto, Portugal from 17–20 September 2024. Co-hosted by ESCMID and ASM, this interdisciplinary summit pledges to tackle the growing threat of AMR, and explore opportunities and outline essential criteria for advancing antimicrobial drug development.

Guidelines & Journals

ESCMID is currently seeking candidates willing to serve on one or more clinical guidelines development panels. Panel members support the development of the guidance documents by revising the protocols, define the scope and focus, assess related literature, and revise the manuscript.

There are four projects that will need panel members, and interested persons can review the full details and apply on our website. Deadline to apply is 1 October 2024.

The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France

Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19